KRAS and pachyonychia congenita: Of the articles included, 11 presented functional extracts or isolated compounds that showed antitumor activity through apoptosis, 5 described functional extracts that altered the pathways activated by the mutation in the KRAS gene, 7 demonstrated cell death due to cell cycle arrest cell and 4 other articles describe other actions through important factors in PC.